Entity
Company
Location
55 Cambridge Parkway, Suite 800 E, Cambridge, MA
Signature
Flagship Ventures Fund V General Partner LLC, By: /s/ Noubar B. Afeyan Ph.D., Title: Manager
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Flagship Ventures Fund V General Partner LLC:

Stock Role Class Num Shares Value Price $ Report Date Ownership
Sana Biotechnology, Inc. 10%+ Owner Common Stock 11.4M $45.8M $4.00 Jun 6, 2023 By Flagship VentureLabs V, LLC
Sana Biotechnology, Inc. 10%+ Owner Common Stock 10.7M $43M $4.00 Jun 7, 2023 By Flagship Ventures Fund V, L.P.
Sana Biotechnology, Inc. 10%+ Owner Common Stock 9.73M $38.9M $4.00 Jun 6, 2023 By Flagship Pioneering Fund VI, L.P.
Sana Biotechnology, Inc. 10%+ Owner Common Stock 1.38M $5.52M $4.00 Jun 7, 2023 By Flagship V VentureLabs Rx Fund, L.P.
Codiak BioSciences, Inc. 10%+ Owner Common Stock 1.87M Sep 15, 2022 By Flagship Ventures Fund V, L.P.
Codiak BioSciences, Inc. 10%+ Owner Common Stock 1.19M Sep 15, 2022 By Flagship V VentureLabs Rx Fund, L.P.
Codiak BioSciences, Inc. 10%+ Owner Warrants to purchase Common Stock 723K Sep 15, 2022 By Flagship Ventures Fund V, L.P.
Codiak BioSciences, Inc. 10%+ Owner Common Stock 486K Sep 15, 2022 Flagship VentureLabs V LLC
Codiak BioSciences, Inc. 10%+ Owner Warrants to purchase Common Stock 211K Sep 15, 2022 By Flagship V VentureLabs Rx Fund, L.P.
Sigilon Therapeutics, Inc. 10%+ Owner Common Stock 0 Aug 11, 2023 By Flagship Pioneering Special Opportunities Fund II, L.P.
Sigilon Therapeutics, Inc. 10%+ Owner Common Stock 0 Aug 11, 2023 By Flagship Ventures Fund V, L.P.

Insider Reports Filed by Flagship Ventures Fund V General Partner LLC

Symbol Company Period Transactions Value $ Form Type Date Filed Role
SGTX Sigilon Therapeutics, Inc. Aug 11, 2023 2 -$11.9M 4 Aug 15, 2023 10%+ Owner
SANA Sana Biotechnology, Inc. Jun 6, 2023 4 -$2.53M 4 Jun 8, 2023 10%+ Owner
SANA Sana Biotechnology, Inc. May 24, 2023 6 -$3.53M 4 May 26, 2023 10%+ Owner
CDAKQ Codiak BioSciences, Inc. Sep 15, 2022 4 $0 4 Sep 16, 2022 10%+ Owner